tm logo
NEXRETYS
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 05 Feb 2024

Last Applicant/ Owned by

Floor 3, Building 1, 400 Fangchun Road

Shanghai

CN

201207

Serial Number

90302469 filed on 06th Nov 2020

Registration Number

N/A

Correspondent Address

Muzamil Huq

MORRISON & FOERSTER LLP

425 MARKET STREET

SAN FRANCISCO,CA 94105

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NEXRETYS

Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, aRead More

Classification Information


Class [005]
Pharmaceutical Products


Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical diagnostic preparations

Mark Details


Serial Number

No 90302469

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 720626006000

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Feb 2024SOU TEAS EXTENSION RECEIVED
05th Feb 2024SOU EXTENSION 2 FILED
05th Feb 2024SOU EXTENSION 2 GRANTED
22nd Jan 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
22nd Jan 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22nd Jan 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
03rd Jan 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03rd Jan 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Jan 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED